Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
International Journal of Cardiac Imaging
|
August 3, 2001
Dobutamine-induced increase of right ventricular contractility without increased stroke volume in adolescent patients with transposition of the great arteries: evaluation with magnetic resonance imaging
I I Tulevski, P L Lee, M Groenink, et al.
Lancet (London, England)
|
July 31, 1993
Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands
J van der Meer, H L Hillege, G J Kootstra, et al.
Journal of the American College of Cardiology
|
November 30, 1999
Worse clinical outcome but similar graft patency in women versus men one year after coronary artery bypass graft surgery owing to an excess of exposed risk factors in women. CABADAS. Research Group of the Interuniversity Cardiology Institute of The Netherlands. Coronary Artery Bypass graft occlusion by Aspirin, Dipyridamole and Acenocoumarol/phenoprocoumon Study
E S Tan, J van der Meer, P Jan de Kam, et al.
Thrombosis and Haemostasis
|
January 31, 2002
Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism
I I Tulevski, A Hirsch, B J Sanson, et al.
European Heart Journal
|
August 1, 1994
Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting
B J Mulder, R M van der Doef, E E van der Wall, et al.
Heart (British Cardiac Society)
|
June 19, 2001
Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction
I I Tulevski, M Groenink, E E van Der Wall, et al.
Thrombosis and Haemostasis
|
November 1, 1994
Oral anticoagulation in the prevention of one-year vein graft occlusion after aortocoronary bypass surgery: optimal therapeutic range and practical limitations. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands
J van der Meer, H L Hillege, P H Dunselman, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
February 14, 2019
Adults with congenital heart disease: ready for mobile health?
R W Treskes, M Koole, D Kauw, et al.
Thrombosis and Haemostasis
|
January 1, 1996
Aprotinin in aortocoronary bypass surgery: increased risk of vein-graft occlusion and myocardial infarction? Supportive evidence from a retrospective study
J van der Meer, H L Hillege, C A Ascoop, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
September 21, 2016
Mobile health in adults with congenital heart disease: current use and future needs
M J Schuuring, A P Backx, R Zwart, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
International Journal of Cardiac Imaging
|
August 3, 2001
Dobutamine-induced increase of right ventricular contractility without increased stroke volume in adolescent patients with transposition of the great arteries: evaluation with magnetic resonance imaging
I I Tulevski, P L Lee, M Groenink, et al.
Lancet (London, England)
|
July 31, 1993
Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands
J van der Meer, H L Hillege, G J Kootstra, et al.
Journal of the American College of Cardiology
|
November 30, 1999
Worse clinical outcome but similar graft patency in women versus men one year after coronary artery bypass graft surgery owing to an excess of exposed risk factors in women. CABADAS. Research Group of the Interuniversity Cardiology Institute of The Netherlands. Coronary Artery Bypass graft occlusion by Aspirin, Dipyridamole and Acenocoumarol/phenoprocoumon Study
E S Tan, J van der Meer, P Jan de Kam, et al.
Thrombosis and Haemostasis
|
January 31, 2002
Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism
I I Tulevski, A Hirsch, B J Sanson, et al.
European Heart Journal
|
August 1, 1994
Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting
B J Mulder, R M van der Doef, E E van der Wall, et al.
Heart (British Cardiac Society)
|
June 19, 2001
Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction
I I Tulevski, M Groenink, E E van Der Wall, et al.
Thrombosis and Haemostasis
|
November 1, 1994
Oral anticoagulation in the prevention of one-year vein graft occlusion after aortocoronary bypass surgery: optimal therapeutic range and practical limitations. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands
J van der Meer, H L Hillege, P H Dunselman, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
February 14, 2019
Adults with congenital heart disease: ready for mobile health?
R W Treskes, M Koole, D Kauw, et al.
Thrombosis and Haemostasis
|
January 1, 1996
Aprotinin in aortocoronary bypass surgery: increased risk of vein-graft occlusion and myocardial infarction? Supportive evidence from a retrospective study
J van der Meer, H L Hillege, C A Ascoop, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
September 21, 2016
Mobile health in adults with congenital heart disease: current use and future needs
M J Schuuring, A P Backx, R Zwart, et al.
Page
of 4